[
    [
        {
            "time": "",
            "original_text": "抗疫一年医药股谁最挣钱？英科医疗净利领涨，疫情消退考验“金域医学们”业绩持久性",
            "features": {
                "keywords": [
                    "抗疫",
                    "医药股",
                    "英科医疗",
                    "净利",
                    "疫情",
                    "金域医学",
                    "业绩持久性"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "抗疫一年医药股谁最挣钱？英科医疗净利领涨，疫情消退考验“金域医学们”业绩持久性",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "金域医学：股东国创开元减持计划时间已过半，累计减持0.04%股份 拟减持股份",
            "features": {
                "keywords": [
                    "金域医学",
                    "国创开元",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学：股东国创开元减持计划时间已过半，累计减持0.04%股份 拟减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "金域医学(603882.SH)：国创开元减持期过半累计减持18.32万股 减持股份",
            "features": {
                "keywords": [
                    "金域医学",
                    "国创开元",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学(603882.SH)：国创开元减持期过半累计减持18.32万股 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：第四批集采落地 建议上游原料药行业",
            "features": {
                "keywords": [
                    "医药生物",
                    "集采",
                    "上游",
                    "原料药"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：第四批集采落地 建议上游原料药行业",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "金域医学党委书记、董事长兼首席执行官梁耀铭：发挥专业参与健康乡村建设 助力乡村振兴",
            "features": {
                "keywords": [
                    "金域医学",
                    "梁耀铭",
                    "健康乡村",
                    "乡村振兴"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "金域医学党委书记、董事长兼首席执行官梁耀铭：发挥专业参与健康乡村建设 助力乡村振兴",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]